View ValuationDev Labtech Venture 将来の成長Future 基準チェック /06現在、 Dev Labtech Ventureの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Luxury 収益成長21.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesNew Risk • Jan 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.6% average weekly change). High level of non-cash earnings (23% accrual ratio). Shareholders have been substantially diluted in the past year (43% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$16.5m).New Risk • Dec 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Shareholders have been substantially diluted in the past year (49% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (₹1.08b market cap, or US$11.9m).New Risk • Nov 14New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 49% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Shareholders have been substantially diluted in the past year (49% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹945.9m market cap, or US$10.7m).お知らせ • Nov 08Dev Labtech Venture Limited to Report Q2, 2026 Results on Nov 12, 2025Dev Labtech Venture Limited announced that they will report Q2, 2026 results on Nov 12, 2025Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹1.31 (vs ₹1.62 in FY 2024)Full year 2025 results: EPS: ₹1.31 (down from ₹1.62 in FY 2024). Revenue: ₹524.1m (up 21% from FY 2024). Net income: ₹12.9m (down 3.5% from FY 2024). Profit margin: 2.5% (down from 3.1% in FY 2024). The decrease in margin was driven by higher expenses.お知らせ • Sep 01Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2025Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2025, at 13:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Aug 18Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹65.50, the stock trades at a trailing P/E ratio of 60.1x. Average trailing P/E is 24x in the Luxury industry in India. Total loss to shareholders of 23% over the past year.New Risk • Aug 13New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹856.5m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$10m (₹856.5m market cap, or US$9.79m). Minor Risk Shareholders have been diluted in the past year (23% increase in shares outstanding).New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 7.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.2% average weekly change). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹818.6m market cap, or US$9.55m).Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹79.87, the stock trades at a trailing P/E ratio of 73.2x. Average trailing P/E is 27x in the Luxury industry in India. Total loss to shareholders of 24% over the past year.New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (37% increase in shares outstanding). Market cap is less than US$10m (₹757.3m market cap, or US$8.85m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (8.5% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.9m).お知らせ • May 13Dev Labtech Venture Limited to Report Fiscal Year 2025 Results on May 20, 2025Dev Labtech Venture Limited announced that they will report fiscal year 2025 results on May 20, 2025New Risk • May 13New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (37% increase in shares outstanding). Market cap is less than US$10m (₹703.6m market cap, or US$8.28m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.9m).New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Market cap is less than US$10m (₹679.3m market cap, or US$7.87m). Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.8m).New Risk • Feb 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 30% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Market cap is less than US$10m (₹700.9m market cap, or US$8.07m). Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.8m).Reported Earnings • Oct 29First half 2025 earnings released: EPS: ₹0.47 (vs ₹1.81 in 1H 2024)First half 2025 results: EPS: ₹0.47 (down from ₹1.81 in 1H 2024). Revenue: ₹195.1m (down 6.8% from 1H 2024). Net income: ₹4.85m (down 63% from 1H 2024). Profit margin: 2.5% (down from 6.2% in 1H 2024). The decrease in margin was driven by lower revenue.New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.2% Last year net profit margin: 4.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). High level of non-cash earnings (54% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (₹418m revenue, or US$5.0m). Market cap is less than US$100m (₹884.3m market cap, or US$10.5m).お知らせ • Oct 21Dev Labtech Venture Limited to Report Q2, 2025 Results on Oct 25, 2024Dev Labtech Venture Limited announced that they will report Q2, 2025 results on Oct 25, 2024Valuation Update With 7 Day Price Move • Sep 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹89.94, the stock trades at a trailing P/E ratio of 64.5x. Average trailing P/E is 31x in the Luxury industry in India. Total returns to shareholders of 52% over the past year.お知らせ • Sep 04Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2024Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2024, at 17:00 Indian Standard Time. Location: hotel the basil park, 5, iskon megacity, opp. victoria park, bhavnagar - 364002, bhavnagar IndiaNew Risk • Jul 24New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹829.9m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (61% accrual ratio). Market cap is less than US$10m (₹829.9m market cap, or US$9.91m). Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (8.0% increase in shares outstanding).New Risk • Jun 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (61% accrual ratio). Minor Risks Shareholders have been diluted in the past year (8.0% increase in shares outstanding). Market cap is less than US$100m (₹917.0m market cap, or US$11.0m).New Risk • May 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (85% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Market cap is less than US$100m (₹848.6m market cap, or US$10.2m).Valuation Update With 7 Day Price Move • May 21Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to ₹99.30, the stock trades at a trailing P/E ratio of 46.8x. Average trailing P/E is 28x in the Luxury industry in India. Total returns to shareholders of 69% over the past year.Valuation Update With 7 Day Price Move • Apr 25Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹133, the stock trades at a trailing P/E ratio of 62.6x. Average trailing P/E is 29x in the Luxury industry in India. Total returns to shareholders of 124% over the past year.Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹119, the stock trades at a trailing P/E ratio of 55.8x. Average trailing P/E is 30x in the Luxury industry in India. Total returns to shareholders of 139% over the past year.Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹93.70, the stock trades at a trailing P/E ratio of 44.1x. Average trailing P/E is 27x in the Luxury industry in India.Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹101, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 31x in the Luxury industry in India.Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹104, the stock trades at a trailing P/E ratio of 49.1x. Average trailing P/E is 30x in the Luxury industry in India.Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹115, the stock trades at a trailing P/E ratio of 54x. Average trailing P/E is 29x in the Luxury industry in India.お知らせ • Jan 01Dev Labtech Venture Limited Applies for Solar Power Project of 1300 KV (DC) in Gujarat Energy Development AgencyDev Labtech Venture Limited applied Solar Power Project of 1300 KV (DC) in Gujarat Energy Development Agency (GEDA) for the Captive use for Growing Lab grown CVD diamond. Lab-grown diamonds are also known as synthetic diamonds which are artificially manufactured diamonds that have the same chemical and physical properties as naturally occurred diamonds. These are produced in a labs, rather than formed by millions of years under the Earth's surface. A CVD diamond is a diamond created by a process called Chemical Vapor Deposition. The process for the same begins with a diamond seed crystal which is typically from a high quality of synthetic diamond, in a vacuum chamber. Natural gas, such as methane, is then pumped into the chamber and broken down into carbon atoms that accumulate on the crystal and form a diamond. Solar power can play a significant role in reducing the costs associated with lab-grown CVD (Chemical Vapor Deposition) diamonds through various mechanisms. Here are some details on how a solar power plant can contribute to cost reduction in the production of lab-grown diamonds: Lab-grown diamonds, particularly those produced through CVD processes, require a substantial amount of energy for their synthesis. By harnessing solar power, a considerable portion of the energy required for the diamond growth process can be obtained for free. This reduces the dependence on traditional energy sources and mitigates the impact of fluctuating energy prices on production costs. Solar power plants generate electricity with minimal operating costs once they are installed. By incorporating solar energy into the production process of lab-grown diamonds, it can benefit from reduced operational costs over the long term. This, in turn, can contribute to overall cost savings and increased competitiveness in the market. The environmental footprint of lab-grown diamond production can be substantial, especially when relying on conventional energy sources. Solar power is a clean and renewable energy source, leading to a significant reduction in carbon emissions and other pollutants associated with energy production. This environmental benefit can also contribute to cost savings by potentially avoiding future environmental regulations and taxes.お知らせ • Dec 22Dev Labtech Venture Limited announced that it has received INR 55.676 million in fundingOn December 21, 2023, Dev Labtech Venture Limited closed the transaction. The transaction included participation from a group of individual investors.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹88.47, the stock trades at a trailing P/E ratio of 41.7x. Average trailing P/E is 26x in the Luxury industry in India.New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (128% accrual ratio). Market cap is less than US$10m (₹710.2m market cap, or US$8.53m). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Revenue is less than US$5m (₹303m revenue, or US$3.6m).Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹85.87, the stock trades at a trailing P/E ratio of 69.7x. Average trailing P/E is 24x in the Luxury industry in India.お知らせ • Oct 26Dev Labtech Venture Limited announced that it expects to receive INR 222.704 million in fundingDev Labtech Venture Limited announced a private placement to issue 35,92,000 convertible warrants convertible into, or exchangeable for one equity share within the period of 18 months in accordance with the applicable laws and regulations at a price of INR 62 per warrant for the aggregate gross proceeds of INR 22,27,04,000 on October 24, 2023. The transaction has been approved by the board of directors of the company. The transaction included participation from a group of individual investors.Reported Earnings • Aug 25Full year 2023 earnings released: EPS: ₹0.96 (vs ₹0.84 in FY 2022)Full year 2023 results: EPS: ₹0.96 (up from ₹0.84 in FY 2022). Revenue: ₹303.4m (up 13% from FY 2022). Net income: ₹10.2m (up 134% from FY 2022). Profit margin: 3.4% (up from 1.6% in FY 2022). The increase in margin was driven by higher revenue.お知らせ • Aug 15Dev Labtech Venture Limited, Annual General Meeting, Sep 09, 2023Dev Labtech Venture Limited, Annual General Meeting, Sep 09, 2023, at 17:00 Indian Standard Time. Location: The Basil Park, 5 Iskon Megacity, Opp Victoria Park Bhavnagar India Agenda: To receive, consider and adopt the Audited Standalone Financial Statements of the company for the financial year ended on 31st March, 2023 together with the report of the Board of Directors and Auditors thereon; To appoint a Director in place of Mr. Jerambhai Lavjibhai Donda, Chairman and Managing Director (DIN: 00484152), who retires by rotation and being eligible offers himself for re-appointment.Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹0.96 (vs ₹0.84 in FY 2022)Full year 2023 results: EPS: ₹0.96 (up from ₹0.84 in FY 2022). Revenue: ₹303.4m (up 13% from FY 2022). Net income: ₹10.2m (up 134% from FY 2022). Profit margin: 3.4% (up from 1.6% in FY 2022). The increase in margin was driven by higher revenue.Board Change • Mar 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brijeshkumar Pathak was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Dev Labtech Venture は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:543848 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/202582111-83-57N/A6/30/202567312-112-94N/A3/31/202552413-141-131N/A12/31/20244719N/AN/AN/A9/30/20244185-151-135N/A6/30/20244259-131-114N/A3/31/202443213-111-93N/A12/31/202342715N/AN/AN/A9/30/202341618-109-100N/A6/30/202336014-105-79N/A3/31/202330310-101-57N/A3/31/2022270522N/A3/31/20211220-1-1N/A3/31/2020118033N/A3/31/20192591N/A-8N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 543848の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 543848の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 543848の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 543848の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 543848の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 543848の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YConsumer-durables 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 13:50終値2026/05/07 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Dev Labtech Venture Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Jan 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.6% average weekly change). High level of non-cash earnings (23% accrual ratio). Shareholders have been substantially diluted in the past year (43% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$16.5m).
New Risk • Dec 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Shareholders have been substantially diluted in the past year (49% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (₹1.08b market cap, or US$11.9m).
New Risk • Nov 14New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 49% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Shareholders have been substantially diluted in the past year (49% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹945.9m market cap, or US$10.7m).
お知らせ • Nov 08Dev Labtech Venture Limited to Report Q2, 2026 Results on Nov 12, 2025Dev Labtech Venture Limited announced that they will report Q2, 2026 results on Nov 12, 2025
Reported Earnings • Sep 08Full year 2025 earnings released: EPS: ₹1.31 (vs ₹1.62 in FY 2024)Full year 2025 results: EPS: ₹1.31 (down from ₹1.62 in FY 2024). Revenue: ₹524.1m (up 21% from FY 2024). Net income: ₹12.9m (down 3.5% from FY 2024). Profit margin: 2.5% (down from 3.1% in FY 2024). The decrease in margin was driven by higher expenses.
お知らせ • Sep 01Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2025Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2025, at 13:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Aug 18Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹65.50, the stock trades at a trailing P/E ratio of 60.1x. Average trailing P/E is 24x in the Luxury industry in India. Total loss to shareholders of 23% over the past year.
New Risk • Aug 13New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹856.5m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$10m (₹856.5m market cap, or US$9.79m). Minor Risk Shareholders have been diluted in the past year (23% increase in shares outstanding).
New Risk • Jul 08New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 7.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.2% average weekly change). Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₹818.6m market cap, or US$9.55m).
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹79.87, the stock trades at a trailing P/E ratio of 73.2x. Average trailing P/E is 27x in the Luxury industry in India. Total loss to shareholders of 24% over the past year.
New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (37% increase in shares outstanding). Market cap is less than US$10m (₹757.3m market cap, or US$8.85m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (8.5% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.9m).
お知らせ • May 13Dev Labtech Venture Limited to Report Fiscal Year 2025 Results on May 20, 2025Dev Labtech Venture Limited announced that they will report fiscal year 2025 results on May 20, 2025
New Risk • May 13New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (37% increase in shares outstanding). Market cap is less than US$10m (₹703.6m market cap, or US$8.28m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.9m).
New Risk • Mar 19New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Market cap is less than US$10m (₹679.3m market cap, or US$7.87m). Minor Risks Share price has been volatile over the past 3 months (8.1% average weekly change). Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.8m).
New Risk • Feb 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 30% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (54% accrual ratio). Shareholders have been substantially diluted in the past year (30% increase in shares outstanding). Market cap is less than US$10m (₹700.9m market cap, or US$8.07m). Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Revenue is less than US$5m (₹418m revenue, or US$4.8m).
Reported Earnings • Oct 29First half 2025 earnings released: EPS: ₹0.47 (vs ₹1.81 in 1H 2024)First half 2025 results: EPS: ₹0.47 (down from ₹1.81 in 1H 2024). Revenue: ₹195.1m (down 6.8% from 1H 2024). Net income: ₹4.85m (down 63% from 1H 2024). Profit margin: 2.5% (down from 6.2% in 1H 2024). The decrease in margin was driven by lower revenue.
New Risk • Oct 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.2% Last year net profit margin: 4.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). High level of non-cash earnings (54% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (₹418m revenue, or US$5.0m). Market cap is less than US$100m (₹884.3m market cap, or US$10.5m).
お知らせ • Oct 21Dev Labtech Venture Limited to Report Q2, 2025 Results on Oct 25, 2024Dev Labtech Venture Limited announced that they will report Q2, 2025 results on Oct 25, 2024
Valuation Update With 7 Day Price Move • Sep 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹89.94, the stock trades at a trailing P/E ratio of 64.5x. Average trailing P/E is 31x in the Luxury industry in India. Total returns to shareholders of 52% over the past year.
お知らせ • Sep 04Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2024Dev Labtech Venture Limited, Annual General Meeting, Sep 27, 2024, at 17:00 Indian Standard Time. Location: hotel the basil park, 5, iskon megacity, opp. victoria park, bhavnagar - 364002, bhavnagar India
New Risk • Jul 24New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹829.9m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (61% accrual ratio). Market cap is less than US$10m (₹829.9m market cap, or US$9.91m). Minor Risks Share price has been volatile over the past 3 months (9.5% average weekly change). Shareholders have been diluted in the past year (8.0% increase in shares outstanding).
New Risk • Jun 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 8.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (61% accrual ratio). Minor Risks Shareholders have been diluted in the past year (8.0% increase in shares outstanding). Market cap is less than US$100m (₹917.0m market cap, or US$11.0m).
New Risk • May 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). High level of non-cash earnings (85% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Market cap is less than US$100m (₹848.6m market cap, or US$10.2m).
Valuation Update With 7 Day Price Move • May 21Investor sentiment deteriorates as stock falls 24%After last week's 24% share price decline to ₹99.30, the stock trades at a trailing P/E ratio of 46.8x. Average trailing P/E is 28x in the Luxury industry in India. Total returns to shareholders of 69% over the past year.
Valuation Update With 7 Day Price Move • Apr 25Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹133, the stock trades at a trailing P/E ratio of 62.6x. Average trailing P/E is 29x in the Luxury industry in India. Total returns to shareholders of 124% over the past year.
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹119, the stock trades at a trailing P/E ratio of 55.8x. Average trailing P/E is 30x in the Luxury industry in India. Total returns to shareholders of 139% over the past year.
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹93.70, the stock trades at a trailing P/E ratio of 44.1x. Average trailing P/E is 27x in the Luxury industry in India.
Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹101, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 31x in the Luxury industry in India.
Valuation Update With 7 Day Price Move • Feb 06Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹104, the stock trades at a trailing P/E ratio of 49.1x. Average trailing P/E is 30x in the Luxury industry in India.
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹115, the stock trades at a trailing P/E ratio of 54x. Average trailing P/E is 29x in the Luxury industry in India.
お知らせ • Jan 01Dev Labtech Venture Limited Applies for Solar Power Project of 1300 KV (DC) in Gujarat Energy Development AgencyDev Labtech Venture Limited applied Solar Power Project of 1300 KV (DC) in Gujarat Energy Development Agency (GEDA) for the Captive use for Growing Lab grown CVD diamond. Lab-grown diamonds are also known as synthetic diamonds which are artificially manufactured diamonds that have the same chemical and physical properties as naturally occurred diamonds. These are produced in a labs, rather than formed by millions of years under the Earth's surface. A CVD diamond is a diamond created by a process called Chemical Vapor Deposition. The process for the same begins with a diamond seed crystal which is typically from a high quality of synthetic diamond, in a vacuum chamber. Natural gas, such as methane, is then pumped into the chamber and broken down into carbon atoms that accumulate on the crystal and form a diamond. Solar power can play a significant role in reducing the costs associated with lab-grown CVD (Chemical Vapor Deposition) diamonds through various mechanisms. Here are some details on how a solar power plant can contribute to cost reduction in the production of lab-grown diamonds: Lab-grown diamonds, particularly those produced through CVD processes, require a substantial amount of energy for their synthesis. By harnessing solar power, a considerable portion of the energy required for the diamond growth process can be obtained for free. This reduces the dependence on traditional energy sources and mitigates the impact of fluctuating energy prices on production costs. Solar power plants generate electricity with minimal operating costs once they are installed. By incorporating solar energy into the production process of lab-grown diamonds, it can benefit from reduced operational costs over the long term. This, in turn, can contribute to overall cost savings and increased competitiveness in the market. The environmental footprint of lab-grown diamond production can be substantial, especially when relying on conventional energy sources. Solar power is a clean and renewable energy source, leading to a significant reduction in carbon emissions and other pollutants associated with energy production. This environmental benefit can also contribute to cost savings by potentially avoiding future environmental regulations and taxes.
お知らせ • Dec 22Dev Labtech Venture Limited announced that it has received INR 55.676 million in fundingOn December 21, 2023, Dev Labtech Venture Limited closed the transaction. The transaction included participation from a group of individual investors.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹88.47, the stock trades at a trailing P/E ratio of 41.7x. Average trailing P/E is 26x in the Luxury industry in India.
New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (128% accrual ratio). Market cap is less than US$10m (₹710.2m market cap, or US$8.53m). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Revenue is less than US$5m (₹303m revenue, or US$3.6m).
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹85.87, the stock trades at a trailing P/E ratio of 69.7x. Average trailing P/E is 24x in the Luxury industry in India.
お知らせ • Oct 26Dev Labtech Venture Limited announced that it expects to receive INR 222.704 million in fundingDev Labtech Venture Limited announced a private placement to issue 35,92,000 convertible warrants convertible into, or exchangeable for one equity share within the period of 18 months in accordance with the applicable laws and regulations at a price of INR 62 per warrant for the aggregate gross proceeds of INR 22,27,04,000 on October 24, 2023. The transaction has been approved by the board of directors of the company. The transaction included participation from a group of individual investors.
Reported Earnings • Aug 25Full year 2023 earnings released: EPS: ₹0.96 (vs ₹0.84 in FY 2022)Full year 2023 results: EPS: ₹0.96 (up from ₹0.84 in FY 2022). Revenue: ₹303.4m (up 13% from FY 2022). Net income: ₹10.2m (up 134% from FY 2022). Profit margin: 3.4% (up from 1.6% in FY 2022). The increase in margin was driven by higher revenue.
お知らせ • Aug 15Dev Labtech Venture Limited, Annual General Meeting, Sep 09, 2023Dev Labtech Venture Limited, Annual General Meeting, Sep 09, 2023, at 17:00 Indian Standard Time. Location: The Basil Park, 5 Iskon Megacity, Opp Victoria Park Bhavnagar India Agenda: To receive, consider and adopt the Audited Standalone Financial Statements of the company for the financial year ended on 31st March, 2023 together with the report of the Board of Directors and Auditors thereon; To appoint a Director in place of Mr. Jerambhai Lavjibhai Donda, Chairman and Managing Director (DIN: 00484152), who retires by rotation and being eligible offers himself for re-appointment.
Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹0.96 (vs ₹0.84 in FY 2022)Full year 2023 results: EPS: ₹0.96 (up from ₹0.84 in FY 2022). Revenue: ₹303.4m (up 13% from FY 2022). Net income: ₹10.2m (up 134% from FY 2022). Profit margin: 3.4% (up from 1.6% in FY 2022). The increase in margin was driven by higher revenue.
Board Change • Mar 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brijeshkumar Pathak was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.